Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Protein kinase C polymorphisms and vitamin D levels in multiple sclerosis.
Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis.
Synchrony analysis: application in early diagnosis, staging and prognosis of multiple sclerosis.
Dexmedetomidine for monitored anesthesia care in patients undergoing liberation procedure for multiple sclerosis: An observational study.
Non-local spatial regularization of MRI T2 relaxation images for myelin water quantification.
Investigation of cytocrom c oxidase gene subunits expression on the Multiple sclerosis.
Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain.
Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis.
Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound.
Secondary progressive multiple sclerosis: a shared therapeutic decision.
Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase.
Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females.
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.
When does multiple sclerosis start? Three case reports and a review of the literature.
Interlukin-18 Is a Pivot Regulatory Factor on Matrix Metalloproteinase-13 Expression and Brain Astrocytic Migration.
SLAM-SAP Signaling Promotes Differentiation of IL-17-Producing T Cells and Progression of Experimental Autoimmune Encephalomyelitis.
Bringing CLARITY to gray matter atrophy.
Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis.
Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies.
Nonallergic comorbidities of atopic eczema: an overview of systematic reviews.
Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis.
IL-6 and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function.
Multiple sclerosis: Diurnal variations in serum markers of inflammation-an avoidable source of bias in MS studies?
Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach.
Hypomorphic MGAT5 polymorphisms promote multiple sclerosis cooperatively with MGAT1 and interleukin-2 and 7 receptor variants.
Pages
« first
‹ previous
…
369
370
371
372
373
374
375
376
377
…
next ›
last »